Chinese english Germany Japanese Korea

(1S)-1-(Diphenylphosphino)-2-[(1S)-1-[[[1-(phenylmethyl)-1H-benzimidazol-2-yl]methyl]amino]ethyl]ferrocene

(1S)-1-(Diphenylphosphino)-2-[(1S)-1-[[[1-(phenylmethyl)-1H-benzimidazol-2-yl]methyl]amino]ethyl]ferrocene Struktur
2375957-97-2
CAS-Nr.
2375957-97-2
Englisch Name:
(1S)-1-(Diphenylphosphino)-2-[(1S)-1-[[[1-(phenylmethyl)-1H-benzimidazol-2-yl]methyl]amino]ethyl]ferrocene
Synonyma:
(1S)-1-(Diphenylphosphino)-2-[(1S)-1-[[[1-(phenylmethyl)-1H-benzimidazol-2-yl]methyl]amino]ethyl]ferrocene;Ferrocene, 1-(diphenylphosphino)-2-[(1S)-1-[[[1-(phenylmethyl)-1H-benzimidazol-2-yl]methyl]amino]ethyl]-, (1S)-
CBNumber:
CB414011599
Summenformel:
C39H36FeN3P
Molgewicht:
633.54
MOL-Datei:
2375957-97-2.mol
Request For Quotation

(1S)-1-(Diphenylphosphino)-2-[(1S)-1-[[[1-(phenylmethyl)-1H-benzimidazol-2-yl]methyl]amino]ethyl]ferrocene Eigenschaften

Sicherheit

(1S)-1-(Diphenylphosphino)-2-[(1S)-1-[[[1-(phenylmethyl)-1H-benzimidazol-2-yl]methyl]amino]ethyl]ferrocene Chemische Eigenschaften,Einsatz,Produktion Methoden

(1S)-1-(Diphenylphosphino)-2-[(1S)-1-[[[1-(phenylmethyl)-1H-benzimidazol-2-yl]methyl]amino]ethyl]ferrocene Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

(1S)-1-(Diphenylphosphino)-2-[(1S)-1-[[[1-(phenylmethyl)-1H-benzimidazol-2-yl]methyl]amino]ethyl]ferrocene Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 3)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Nanjing Sincerity Chemical Co. Ltd. 025-57621892 13245250309
 hp@njsincerity.com China 296 58
Suzhou Haiben Pharmaceutical Co., Ltd 14760821013 14760821013
 1816280386@qq.com China 6941 58
Shanghai Chemilab Biotechnology CO.,Ltd 18116465878
 kmlb@kaimilaibo.com China 2401 58
  • (1S)-1-(Diphenylphosphino)-2-[(1S)-1-[[[1-(phenylmethyl)-1H-benzimidazol-2-yl]methyl]amino]ethyl]ferrocene
  • Ferrocene, 1-(diphenylphosphino)-2-[(1S)-1-[[[1-(phenylmethyl)-1H-benzimidazol-2-yl]methyl]amino]ethyl]-, (1S)-
  • 2375957-97-2
Copyright 2019 © ChemicalBook. All rights reserved